no Coach is kicked off iHub.
He's a clever troll, that coach. His subject line about misnathrope made me take him off ignore to see how frightened he is of misanthrope. Sure enough, coachypoo is quick to dismiss misnathrope, and Det Thorne, as focusing on the negative, when in fact they are merely focusing on the FACTS.
That's the problem, isn't it Coach? Everyone who focuses on the FACTS sounds negative about BIEL. Hmmm, what could that possibly mean?
Don't answer. Back on Iggy for you.
I wonder how much of your BS you actually believe, coach, and how much is just damage control.
B. Braun? how long have you been pumping B. Braun? 18 months?
Revolutionary technology? you mean the reduced power and tiny size?
"Long Term investors know enough..." to have lost 90% of their investment? Or have you lost 95%?
You don't like anyone trying to tell others to buy or sell? Then why don't you criticize the 20-plus pumptards on iHub telling people to BUY?
I have never told anyone to buy or sell, but you jump all over my posts... especially on iHub... which begs the question: if you don't care about getting kicked off iHub, why do you read it so religiously?
I look at this glass as bone dry until the de novo is submitted in October. "You and others" see this glass as overflowing.
I am weary of this stock. The nonstop BS is tiresome. When Q2 sales numbers get released there will be something to talk about -- not until.
as GetSeriousOK, I haven't posted much in the past couple of months. And I'm WAY more pessimistic about this stock than Thorne or RVC or NoPinkScams.
Draw YOUR own conclusions as to why.
You "longs" are in mind-boggling denial. I haven't seen this kind of denial since the SPNGE shareholders tried to convince themselves and each other that they weren't being cheated. You think the SEC investigation is a good thing, the FDA "delay" is a good thing, the poor Q4 and Q1 sales were a fluke.... Instead of facing reality and expecting Q2 sales of $600,000 you fools are predicting, what, $2 million?
The reason I don't post much is because I am bored with the iHub crowd and their denial. There's nothing real to talk about until Q2 sales come out... and even then, WHEN Q2 SALES ARE TERRIBLE, you "strong buy" fools will just shrug it off and high-five each other and crow about Q3 sales going through the roof. And Andy isn't going to tell you anything more about the FDA submission until October when they announce they are submitting a De Novo with the Oxford study data.
And won't THAT be a high-five event? You bagholders won't care that the company wasted over a year pretending to pursue that 510(k) while they diluted and borrowed and stalled.... And you'll be ignoring the poor Q3 sales by then, crowing about Q4... deja vu.
I don't know whether the PPS is being propped up by one Billion Share Bagholder ir whether you all take turns propping up the PPS but there's no way this ridiculous stocxk should be trading above .0005.
Gramps is a Will Rogers figment of somebody's imagination. I HATE that Will Rogers condescending nonsense on message boards.
He ends sentences with "boys and girls" and "folks." I HATE that on message boards. We ain't yer folks, and we ain't boys or girls.
Gramps is just a foil. Look it up, Grampa.
Look at the dates of the radio interview and BIEL's responses to the FDA.
The radio interview came out April 11th, and Andy disclosed a few things that certainly suggest he had already heard from the FDA: for example, he said the FDA's problem was that they didn't understand how the ActiPatch worked without heat, and he said he planned to submit the Oxford Study results, implying that he was already planning the De Novo at that point.
the PR about BIEL's responses came out May 10th. In that PR the company said "two weeks ago, it submitted detailed responses to the FDA's questions." That is April 26th. How long did the company need to craft that response? Three weeks, at least, wouldn't you think? So put the ballpark date for the FDA's communication at April 5th.
I'm just guessing at these dates. And therein lies the problem with this company: there is inadequate disclosure here.
It will be interesting to see what the company did for financing between April 5th and May 10th, when they knew the 510(k) was dead but didn't tell their shareholders.
Q2 revenue will be about $575,000, maybe $600,000
With the expenses of all their FDA maneuvering and the new strategy of GIVING AWAY THE TRIAL VERSION, operational losses could set a new record.
I hope they split out the sales per country again. That was a revelation in Q1. It showed that sales in the UK fell 10%.
The Daily Mail hype probably caused a spike in sales.... of the TRIAL VERSION. Unfortunately, the Trial Version is a loss leader. They're selling the Trial Version in NZ and Australia. Yep, operational losses could set a new record, all right.
rheumy dewmy boomie,
good lord, you're stupid.
Dilution was "only" 300 million shares last quarter because the SEC told BIEL to cease and desist their illegal dilution scheme. As a result, they BORROWED money instead.
the ActiPatch is an E-Miracle that cures bullet wounds.
And now it seems the shooter was gay. No problem, because Holy Roller Michelle Bachmann's husband will testify that the Actipatch cures gayness.
The big volume day came when BIEL sent a pumpletter to its shareholders only. That means the buyers were existing shareholders who apparently heard what they wanted to hear.
The pumpletter was then posted on BIEL's website, erroneously labeled a "press release." Still, nobody in the biotech arena would find it there -- biotechs are driven by news only, not pump blogs on the company's website.
This is fascinating. BIEL is preaching to their choir and then passing around the collection plate. They are not trying to recruit new members in the Church of BIEL -- they are trying to squeeze more money out of the existing parishoners.
That is not a recipe for metaphysical success.
But who is selling? Why is there an unlimited supply of available shares? Are the Billion Share Bagholders like Simpsy dumping their .0005 shares? Is BIEL dumping more unregistered shares, arrogantly thinking that the SEC can't stop them?
you ABSOLUTELY DO NOT want new investors to "do their own DD." Nobody would buy this stock after doing their own DD.
You want them to read the message boards only, especially iHub, and get suckered into this Ponzi scheme because they are greedy and ignorant.
You know -- the same reasons YOU got suckered in.
They are also giving away a FREE 7-Day Trial unit when you buy a 720-hour version.
The pumptards are claiming BIEL can't keep up with orders when actually they are having the opposite problem.
The Q2 "cost of revenue" is going to be higher than normal. Pity, because they were starting to do a decent job of trimming the fat.
as for arq and edbi -- just put them both on Ignore. They are frauds. I also put CoachHappiness back on Ignore, but you might want to keep reading him since you both go way back.
these pumpers on both boards are not paid. They're just bagholders.
Although I think srinslocal on the hub actually might be Andy.
Writing gibberish in the wee hours of the AM hurts a stock more than helps it.
I understand that you're desperate. But when you write things like
"Take a look at their website at website"
"1.25 billion people after the Actipatch in India -- I will be happy of 0.5% of that and that would be huge."
"check the update under the press release, unless you can't read English."
You sound like some kind of 3rd-world spammer.
Just trying to help, Dewbie. I've decided that you can't possibly be one of the Billion Share Bagholder's Club, so you probably just want out. Hope you get your wish.
"the FDA would have been somewhat intimidated...
"They were super impressed...
"I am sure they were very pleased to have such an elite group present the information requested.
It's one thing for a desperate bagholder to even SAY nonsense like that.... But then you gush all over him and REPEAT IT?
BIEL is about as small as you can get as a biotech and still operate. They live in the Biotech Welfare Halfway House. Let's look at who attended this FDA Meeting:
Whelan: a Marketing Guy who can't pronounce the word "opioid"
Staelin: a Marketing Guy. He presented clinical data? Are you kidding me?
McLeod: he teaches a class in entrepreneurship at Binghampton. He did write some journal articles but it appears he always the 3rd author or lower. He must have helped write the 510(k) that the FDA didn't like. Maybe he knows his PEMF but can he explain it to the FDA?
Rawe: according to the Update, he didn't present anything? He was just there to intimidate the FDA with meaningful stares as he rubbed his knuckles? (He also must have helped write the 510(k) that the FDA didn't like. )
BIEL's Lawyers: oh yeah, The Little Mouse That Roared's lawyers are going to intimidate the FDA. Happens all the time. Those FDA people get intimidated every time they step into a room with some little biotech's LLP lawyers.
In conclusion, BIEL said "the agency would be back to the company shortly with its pathway determination and advice regarding whether additional information is necessary." And guess when BIEL shareholders will find out what the FDA said? If the FDA says "you should try the de novo," you won't hear about it until after October when they get the Oxford data and announce they are submitting a de novo.
You say: 'All we care about right mow is cash flow and increased revenue. We don't to make any money!"
Revenue has flatlined since Q4 2014. Revenue DECREASED in the UK in Q1 despite all the hype about B. Braun and thousands of new shelves. Cash is flowing OUT, not IN, and BIEL resorted to tapping into their Line of Credit since the SEC told them to cease and desist their dilution scheme.
And you bought BIEL "don't to make any money?" You bought a pinksheet stock for a reason other than making money? Fascinating. cathdiamond, please discuss this amongst your split personalities.
GOD THIS STOCK IS FUN!
BIEL posted that "update" on their website Thursday evening. It's on this page:
and a link is on this page:
Here are the first three lines on that page:
Home / Press Release
June 9, 2016 /Press Release
BioElectronics Company Update – June 8, 2016
PROBLEM: it wasn't a Press Release. It was a mass-email sent to BIEL shareholders.
I think Edward Scissorhands Whelan is going to snip out the words "Press Release" within a couple of days because that is an outright lie. It's unusual to catch these pinkie artists in an outright lie.
A Press Release costs only a few hundred bucks. This reminds me of the now-extinct company RXPC -- they couldn't afford press releases so they placed hype in their SEC filings. BIEL places hype in THEIR financial filings too. But calling a mass marketing email a "press release" when it ain't? Even the crooks at RXPC never stooped THAT low.
RXPC released a PR once that was a PDF with a "Trial Version" waterstamp -- they couldn't even buy their PR person licensed software to produce a PDF. Ahhhh, those were the days.